← All companies

COYA

Coya Therapeutics, Inc.

COYA Nasdaq Pharmaceutical Preparations EDGAR ↗

$4.43

+0.35 +8.58%

Key statistics

from XBRL data in SEC filings

Market cap

$104M

Revenue (TTM)

$7.94M

Net income (TTM)

-$21.1M

EPS (TTM)

$-1.15

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$50.7M

Total assets

$53.3M

Gross margin

—

52-week range

$3.71 – $7.75

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 25, 2026 8-K Entered a material agreement May 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release); Other events May 12, 2026 8-K Director or officer change Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Results of operations (earnings release) Mar 16, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jan 30, 2026 8-K Other events Jan 20, 2026 8-K Other events Jan 8, 2026 8-K Other events Dec 17, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 27, 2025 8-K Other events Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Other events Jul 29, 2025 8-K Other events Jul 1, 2025 8-K Shareholder vote results Jun 26, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 13, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 18, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2024 8-K Director or officer change Nov 5, 2024 8-K Director or officer change Oct 31, 2024 8-K Regulation FD disclosure Oct 29, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Oct 22, 2024 8-K Director or officer change; Regulation FD disclosure Aug 19, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2024 8-K Other events Jul 15, 2024 8-K Entered a material agreement Jun 5, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 20, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2024 8-K Director or officer change; Shareholder vote results May 8, 2024